Marmoset monkey model of Zika virus infection offers new insights into the human condition

May 03, 2018

A novel marmoset model of human Zika virus infection offers new opportunities for better understanding of how the virus causes congenital disease in humans. The researchers found that infection of marmoset dams recapitulates the human infection more faithfully than infections in other animal models, providing opportunities to study disease repercussions in ways that were not previously available. The study appears in the journal Scientific Reports.

"We were interested in using primate models to better understand how the Zika virus spreads from the mom to the fetus," said first author Dr. Maxim Seferovic, a postdoctoral associate in obstetrics and gynecology at Baylor College of Medicine. "We found that the available models, including several mouse models as well as rhesus, pigtail and macaque models, were not accurately replicating what we see in humans and had several limitations."

The researchers decided to work with the common marmoset, a non-human primate, because their work had previously shown that the marmoset offered several advantages over other animal models. For instance, other human viral infections, such as those caused by Lassa virus, Ebola/Marbug virus and dengue and West Nile virus, can be reproduced in the common marmoset. Also, the researchers had shown before that Zika virus infection in male common marmosets resembles many aspects of the infection seen in humans. When combined with the research team's previous work showing the importance of relatively longer periods of placental growth in successful marmoset pregnancies, these small New World monkeys were ideal models to study congenital Zika syndrome.

"We had previously demonstrated that Zika virus replicates in placental cells isolated from normal human term pregnancies, enabling the placenta to serve as a reservoir for the virus and an eventual portal to the developing fetus. When combined with our initial infection data in male marmosets, we were encouraged to determine whether infection of marmoset dams would more faithfully recapitulate maternal infection observed in humans when compared to mouse models," said corresponding author Dr. Kjersti Aagaard, professor of obstetrics and gynecology at Baylor and Texas Children's Hospital.

A novel animal model for Zika virus congenital syndrome

"We found that the common marmoset does faithfully recapitulate the human disease, including spontaneous demise and pregnancy loss, which is accompanied by infection and destruction in the brain of the fetus. We also learned something new -- that the marmoset presented with an unexpectedly high rate of pregnancy loss. This will now prompt us to look back carefully for additional evidence of pregnancy loss and miscarriage in infected human patient populations," said Aagard, who also is professor of molecular and human genetics, molecular and cell biology and molecular physiology and biophysics.

Interestingly, the researchers also observed that the virus replicates the most in the marmoset placenta; however, they saw no evidence of robust inflammation in the placenta itself. On the other hand, they did see evidence that the dam can recognize and fight the virus; they determined the presence of antibodies against the virus and an inflammatory response in the dam's blood. These results support previous observations by Aagaard's team and others studying Zika infection in human pregnancies, but more studies are needed to explain the lack of immune response in the marmoset placenta.

"Importantly, this study provides a novel model that faithfully recapitulates human congenital Zika syndrome," said Aagaard, who also is a maternal-fetal medicine specialist working with high-risk pregnancies at Ben Taub and Texas Children's Hospital. "We anticipate that the marmoset model will likely provide new insights into Zika congenital infections that would potentially lead to effective preventive and therapeutic strategies in the future."
-end-
Other contributors to this study include Claudia Sánchez¬San Martín, Suzette D. Tardif, Julienne Rutherford, Eumenia C.C. Castro, Tony Li, Vida L. Hodara, Laura M. Parodi, Luis Giavedoni, Donna Layne-Colon, Manasi Tamhankar, Shigeo Yagi, Calla Martyn, Kevin Reyes, Melissa Suter, Charles Y. Chiu and Jean L. Patterson. The authors are affiliated with one or more of the following institutions: Baylor College of Medicine, Texas Children's Hospital, University of California at San Francisco, Texas Biomedical Research Institute at San Antonio, University of Illinois at Chicago and California Department of Public Health.

This study was supported in part by the National Institutes of Health grants R01-HL105704, R21-AI129455, R24-DK090964, R01-HD091731 and R01 DK089201. The animal work in this study was supported by the Southwest National Primate Research Center (P51-OD11133) and Texas Biomedical Research Institute.

Baylor College of Medicine

Related Infection Articles from Brightsurf:

Halving the risk of infection following surgery
New analysis by the University of Leeds and the University of Bern of more than 14,000 operations has found that using alcoholic chlorhexidine gluconate (CHG) halves the risk of infection in certain types of surgery when compared to the more commonly used povidone-iodine (PVI).

How plants shut the door on infection
A new study by an international team including University of Maryland scientists has discovered the key calcium channel responsible for closing plant pores as an immune response to pathogen exposure.

Sensing infection, suppressing regeneration
UIC researchers describe an enzyme that blocks the ability of blood vessel cells to self-heal.

Boost to lung immunity following infection
The strength of the immune system in response to respiratory infections is constantly changing, depending on the history of previous, unrelated infections, according to new research from the Crick.

Is infection after surgery associated with increased long-term risk of infection, death?
Whether experiencing an infection within the first 30 days after surgery is associated with an increased risk of another infection and death within one year was the focus of this observational study that included about 660,000 veterans who underwent major surgery.

Revealed: How E. coli knows how to cause the worst possible infection
The discovery could one day let doctors prevent the infection by allowing E. coli to pass harmlessly through the body.

UK study shows most patients with suspected urinary tract infection and treated with antibiotics actually lack evidence of this infection
New research presented at this week's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands (April 13-16, 2019) shows that only one third of patients that enter the emergency department with suspected urinary tract infection (UTI) actually have evidence of this infection, yet almost all are treated with antibiotics, unnecessarily driving the emergence of antimicrobial resistance.

Bacteria in urine doesn't always indicate infection
Doctors should think carefully before testing patients for a urinary tract infection (UTI) to avoid over-diagnosis and unnecessary antibiotic treatment, according to updated asymptomatic bacteriuria (ASB) guidelines released by the Infectious Diseases Society of America (IDSA) and published in Clinical Infectious Diseases.

Subsidies for infection control to healthcare institutions help reduce infection levels
Researchers compared three types of infection control subsidies and found that under a limited budget, a dollar-for-dollar matching subsidy, in which policymakers match hospital spending for infection control measures, was the most effective at reducing the number of hospital-acquired infections.

Dengue virus infection may cause severe outcomes following Zika virus infection during pregnancy
This study is the first to report a possible mechanism for the enhancement of Zika virus progression during pregnancy in an animal model.

Read More: Infection News and Infection Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.